HIGHLIGHTS
- who: Lars Plambeck et al. from the Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Medical faculty and University Hospital of Cologne, Cologne, Germany have published the research: In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales, in the Journal: (JOURNAL) of 20/04/2022
- what: The authors evaluate the activity of three older and less frequently used antibiotics against MDR Methods: Susceptibility of mecillinam temocillin and nitroxoline was assessed in isolated from urinary specimens with elevated MICs of third-generation cephalosporins. The aim of this study was therefore to determine . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.